UN health agency issues alert on falsified semaglutides used for diabetes treatment, weight loss
The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.
The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.
The spurious semaglutides – of a specific brand Ozempic – were found in Brazil, the United Kingdom in October 2023, and the United States in December 2023, and were delivered through a regular supply chain.
The WHO’s official notice follows reports of “falsified semaglutide products” across all geographical regions from its Global Surveillance and Monitoring System (GSMS) since 2022.
Dr. Yukiko Nakatani, WHO Assistant Director-General for Essential Medicines and Health Products called on all stakeholders to “stop any usage of suspicious medicines and report to relevant authorities.”
Risks
Ozempic’s actual manufacturer confirmed with WHO that the semaglutides were falsified based on batch and serial numbers.
Semaglutides are supposed to help people reduce their blood sugar and appetite levels and the risk of cardiovascular disease. WHO says reports of falsified products increased as demand for the product grew greater.
Consuming falsified or fake products can have harmful and life-threatening effects on one’s body.
Semaglutides are not recommended by WHO for diabetes treatment due to the product’s expensive cost.
Avoid fake products
Dr. Nakatani said the UN health agency advised healthcare professionals, regulatory authorities and the public to “be aware of these falsified batches of medicines.”
It added that healthcare professionals “should report any incident of adverse effects, lack of effectiveness and suspected falsification to the National Regulatory Authorities/National Pharmacovigilance Centre.”
WHO also advised individuals who may have fake products not to use them and to seek medical assistance if they have used them and experienced side effects.
Avoid unfamiliar sources
To avoid any such scenario, WHO urged people to purchase prescribed products from licensed physicians rather than online or from unfamiliar sources.
WHO added that people should use the products as prescribed and should check for lot and serial numbers, examine the product itself and assess the label quality to ensure the product being used isn’t falsified.
© UN News (2024) — All Rights Reserved. Original source: UN News
Where next?
Browse related news topics:
Read the latest news stories:
- Will the Song “White Christmas” Become a Clarion Call for Climate Change Action? Monday, December 15, 2025
- Will Low Fertility Rates Return to the Replacement Level Any Time Soon? Monday, December 15, 2025
- As Attacks on Women Defenders Intensify, so Must Our Support Monday, December 15, 2025
- Venezuela Needs More Local Data To Understand the Impacts of Climate Change Monday, December 15, 2025
- UNDP’s Digital Rights Dashboard: A Conversation Starter on Human Rights in the Digital Age Monday, December 15, 2025
- Corruption costs lives and livelihoods: Why this week’s UN summit in Doha matters Monday, December 15, 2025
- Six peacekeepers laid to rest following deadly drone attack in Sudan Monday, December 15, 2025
- World News in Brief: Türk condemns ‘abhorrent’ attack in Sydney, UNHCR chief calls for solidarity with refugees, Ukraine latest Monday, December 15, 2025
- Ex-UN chief Ban warns Security Council risks irrelevance without reform Monday, December 15, 2025
- From Tbilisi courtyards to virtual rooms, young women reimagine peace across divides Monday, December 15, 2025
Learn more about the related issues: